國立虎尾科技大學 |

Personalised Health Care = Fostering Precision Medicine Advancements for Gaining Population Health Impact /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Personalised Health Care/ edited by Stefania Boccia, Róza Ádány, Paolo Villari, Martina C. Cornel, Corrado De Vito, Roberta Pastorino.
Reminder of title:	Fostering Precision Medicine Advancements for Gaining Population Health Impact /
other author:	Boccia, Stefania.
Description:	XIX, 120 p. 15 illus., 13 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Health promotion. -
Online resource:	https://doi.org/10.1007/978-3-030-52399-2
ISBN:	9783030523992

Personalised Health Care = Fostering Precision Medicine Advancements for Gaining Population Health Impact /
Personalised Health CareFostering Precision Medicine Advancements for Gaining Population Health Impact /[electronic resource] :edited by Stefania Boccia, Róza Ádány, Paolo Villari, Martina C. Cornel, Corrado De Vito, Roberta Pastorino. - 1st ed. 2021. - XIX, 120 p. 15 illus., 13 illus. in color.online resource. - SpringerBriefs in Public Health,2192-3701. - SpringerBriefs in Public Health,.

Introduction (Boccia) -- 1. Chapter 1: Identification of biomarkers for the prevention of chronic disease (Editors: Adany, Boccia) -- 2. Chapter 2: Evaluation of predictive genomic applications (Editor: Villari). -3. Chapter 3: Ethico-legal and policy issues surrounding personalised medicine (Editor: Sandor) -- olicy issue, with a focus on citizens and DTC) 3.4 Sandor (Legal issue) -- 4. Chapter 4: Roles and responsibilities of stakeholders in informing healthy individuals on their genome: a sociotechnical analysis (Editor: Cornel) -- 5. Chapter 5: Identification of organizational models for the provision of predictive genomic applications (Editor: De Vito).

Practitioners are increasingly adopting a personalised medicine approach to individually tailored patient care, especially disease diagnosis and treatment with the use of biomarkers. However, development and implementation of such approaches to chronic disease prevention need further investigation and concerted efforts for proper use in healthcare systems. This book provides high-quality, multidisciplinary knowledge from research in personalised medicine, specifically personalised prevention of chronic disease. It addresses different perspectives of prevention in the field, and is the outcome of a four-year work of the Personalized prevention of Chronic Disease (PRECeDI) Consortium, a multi-disciplinary and multi-professional team of experts. The Consortium jointly agreed to document and address the five aspects or domains of personalised medicine and prevention as individual chapters: • Identification of biomarkers for the prevention of chronic disease • Evaluation of predictive genomic applications • Ethico-legal and policy issues surrounding personalised medicine • Roles and responsibilities of stakeholders in informing healthy individuals on their genome: a sociotechnical analysis • Identification of organisational models for the provision of predictive genomic applications The book focuses on the Consortium's recommendations that are derived from each of these domains based on up-to-date evidence and research that the authors write, follow, and systematically organise and report. Personalisation of health care is, eventually, a driver of innovation in research and healthcare systems. With this SpringerBrief on Personalised Health Care: Fostering Precision Medicine Advancements for Gaining Population Health Impact, the Consortium provides further evidence of the clinical validity and utility of personalised medicine with special emphasis on the prevention of chronic diseases. The book is a useful resource for policy makers, industry and healthcare professionals, scientists, technology-sector professionals, investors, citizens, and private companies that need proper advice to realise the potential of personalised medicine.

ISBN: 9783030523992

Standard No.: 10.1007/978-3-030-52399-2doiSubjects--Topical Terms:

565089
Health promotion.

LC Class. No.: RA427.8

Dewey Class. No.: 613

Personalised Health Care = Fostering Precision Medicine Advancements for Gaining Population Health Impact /
LDR:04344nam a22004095i 4500 001 1049165
003 DE-He213
005 20210817035701.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030523992 $9 978-3-030-52399-2
024 7 $a 10.1007/978-3-030-52399-2 $2 doi
035 $a 978-3-030-52399-2
050 4 $a RA427.8
072 7 $a MBN $2 bicssc
072 7 $a MED076000 $2 bisacsh
072 7 $a MBN $2 thema
082 0 4 $a 613 $2 23
082 0 4 $a 614.44 $2 23
245 1 0 $a Personalised Health Care $h [electronic resource] : $b Fostering Precision Medicine Advancements for Gaining Population Health Impact / $c edited by Stefania Boccia, Róza Ádány, Paolo Villari, Martina C. Cornel, Corrado De Vito, Roberta Pastorino.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a XIX, 120 p. 15 illus., 13 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a SpringerBriefs in Public Health, $x 2192-3701
505 0 $a Introduction (Boccia) -- 1. Chapter 1: Identification of biomarkers for the prevention of chronic disease (Editors: Adany, Boccia) -- 2. Chapter 2: Evaluation of predictive genomic applications (Editor: Villari). -3. Chapter 3: Ethico-legal and policy issues surrounding personalised medicine (Editor: Sandor) -- olicy issue, with a focus on citizens and DTC) 3.4 Sandor (Legal issue) -- 4. Chapter 4: Roles and responsibilities of stakeholders in informing healthy individuals on their genome: a sociotechnical analysis (Editor: Cornel) -- 5. Chapter 5: Identification of organizational models for the provision of predictive genomic applications (Editor: De Vito).
520 $a Practitioners are increasingly adopting a personalised medicine approach to individually tailored patient care, especially disease diagnosis and treatment with the use of biomarkers. However, development and implementation of such approaches to chronic disease prevention need further investigation and concerted efforts for proper use in healthcare systems. This book provides high-quality, multidisciplinary knowledge from research in personalised medicine, specifically personalised prevention of chronic disease. It addresses different perspectives of prevention in the field, and is the outcome of a four-year work of the Personalized prevention of Chronic Disease (PRECeDI) Consortium, a multi-disciplinary and multi-professional team of experts. The Consortium jointly agreed to document and address the five aspects or domains of personalised medicine and prevention as individual chapters: • Identification of biomarkers for the prevention of chronic disease • Evaluation of predictive genomic applications • Ethico-legal and policy issues surrounding personalised medicine • Roles and responsibilities of stakeholders in informing healthy individuals on their genome: a sociotechnical analysis • Identification of organisational models for the provision of predictive genomic applications The book focuses on the Consortium's recommendations that are derived from each of these domains based on up-to-date evidence and research that the authors write, follow, and systematically organise and report. Personalisation of health care is, eventually, a driver of innovation in research and healthcare systems. With this SpringerBrief on Personalised Health Care: Fostering Precision Medicine Advancements for Gaining Population Health Impact, the Consortium provides further evidence of the clinical validity and utility of personalised medicine with special emphasis on the prevention of chronic diseases. The book is a useful resource for policy makers, industry and healthcare professionals, scientists, technology-sector professionals, investors, citizens, and private companies that need proper advice to realise the potential of personalised medicine.
650 0 $a Health promotion. $3 565089
650 0 $a Human genetics. $3 596505
650 0 $a Medical policy. $3 570081
650 0 $a Ethics. $3 555769
650 0 $a Medical laws and legislation. $3 567375
650 0 $a Genetics. $3 578972
650 1 4 $a Health Promotion and Disease Prevention. $3 593964
650 2 4 $a Human Genetics. $3 593893
650 2 4 $a Health Policy. $3 577593
650 2 4 $a Medical Law. $3 671732
650 2 4 $a Genetics and Genomics. $3 1229010
700 1 $a Boccia, Stefania. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1024635
700 1 $a Ádány, Róza. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1353223
700 1 $a Villari, Paolo. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1262989
700 1 $a Cornel, Martina C. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1353224
700 1 $a De Vito, Corrado. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1353225
700 1 $a Pastorino, Roberta. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1353226
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030523985
776 0 8 $i Printed edition: $z 9783030524005
830 0 $a SpringerBriefs in Public Health, $x 2192-3698 $3 1253815
856 4 0 $u https://doi.org/10.1007/978-3-030-52399-2
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)